| P2093 | author name string | K Watanabe | |
| | R Henriksson | |
| | A Teramoto | |
| | D Yoshida | |
| | M Noha | |
| | T Bergenheim | |
| P2860 | cites work | Pharmacokinetics and pharmacodynamics of estramustine phosphate | Q28265562 |
| | Drug-induced apoptosis by anti-microtubule agent, estramustine phosphate on human malignant glioma cell line, U87MG; in vitro study | Q30923013 |
| | Regulation of apoptosis: involvement of Bcl-2-related proteins | Q33604784 |
| | Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans | Q35975702 |
| | DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain--suggesting an apoptotic cell death | Q36080790 |
| | Cytoskeletal remodeling during growth cone-target interactions | Q36232984 |
| | Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action | Q36588623 |
| | Specific binding of estramustine to prostatic proteins | Q40179009 |
| | Apoptosis in cancer therapy: crossing the threshold | Q40694262 |
| | Apoptosis induction via microtubule disassembly by an antitumour compound, pironetin. | Q40953538 |
| | Tumor blood flow and the cytotoxic effects of estramustine and its constituents in a rat glioma model. | Q41102428 |
| | Targeting microtubule-associated proteins in glioblastoma: a new strategy for selective therapy | Q41154832 |
| | Estramustine in malignant glioma | Q41158465 |
| | In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate | Q41179205 |
| | Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. | Q41328186 |
| | Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes | Q41470785 |
| | Estramustine and estrone analogs rapidly and reversibly inhibit deoxyribonucleic acid synthesis and alter morphology in cultured human glioblastoma cells | Q41571012 |
| | Early morphological detection of estramustine cytotoxicity measured as alteration in cell size and shape by a new technique of microperifusion | Q41704627 |
| | Effects of radiotherapy and estramustine on the microvasculature in malignant glioma | Q41810033 |
| | Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion | Q41912789 |
| | Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study | Q42173013 |
| | Role of microtubules in glucose uptake by C6 glioma cells | Q42462789 |
| | Accumulation of estramustine and estromustine in adipose tissue of rats and humans | Q46339279 |
| | Determinants of human astrocytoma migration | Q48088804 |
| | Estramustine sensitizes human glioblastoma cells to irradiation | Q48156446 |
| | The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables | Q48483676 |
| | Effect of estramustine phosphate on the assembly of isolated bovine brain microtubules and fast axonal transport in the frog sciatic nerve. | Q48495025 |
| | Distribution of estramustine in the BT4C rat glioma model | Q48520241 |
| | Estramustine binding protein in human brain-tumor tissue | Q48717231 |
| | Quantitative methods for scoring cell migration and invasion in filter-based assays. | Q50778274 |
| | Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. | Q55478185 |
| | Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma. | Q55481754 |
| | Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. | Q55482701 |
| | Alterations in slow transport kinetics induced by estramustine phosphate, an agent binding to microtubule-associated proteins | Q67542649 |
| | Disruption of microtubules inhibits the stimulation of tissue plasminogen activator expression and promotes plasminogen activator inhibitor type 1 expression in human endothelial cells | Q68224740 |
| | Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms | Q69372459 |
| | Taxol induces bcl-2 phosphorylation and death of prostate cancer cells | Q71102448 |
| | Clinical and biological studies of estramustine phosphate as a novel radiation sensitizer | Q72000402 |
| | Estramustine: a novel radiation enhancer in human carcinoma cells | Q72691279 |
| | Estramustine phosphate but not estramustine inhibits the interaction of microtubule associated protein 2 (MAP2) with actin filaments | Q73094710 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 37-47 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | The bleb formation of the extracellular pseudopodia; early evidence of microtubule depolymerization by estramustine phosphate in glioma cell; in vitro study | |
| P478 | volume | 52 | |